physostigmine salicylate has been researched along with soman in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buccafusco, JJ; Chon, SH; Heithold, DL | 1 |
| Benschop, HP; De Bisschop, HC; Johnson, MK; Read, DJ; Willems, JL | 1 |
2 other study(ies) available for physostigmine salicylate and soman
| Article | Year |
|---|---|
Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine.
Topics: Animals; Behavior, Animal; Clonidine; Dose-Response Relationship, Drug; Injections, Intramuscular; Lethal Dose 50; Male; Physostigmine; Rats; Rats, Inbred Strains; Soman; Trihexyphenidyl | 1990 |
High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not.
Topics: Animals; Ataxia; Atropine; Carboxylic Ester Hydrolases; Chickens; Diazepam; Drug Interactions; Female; Isoflurophate; Isomerism; Organophosphates; Organophosphorus Compounds; Physostigmine; Soman | 1988 |